Counterpoint Mutual Funds LLC Buys New Holdings in Leidos Holdings, Inc. $LDOS

Counterpoint Mutual Funds LLC purchased a new position in Leidos Holdings, Inc. (NYSE:LDOS) during the first quarter, HoldingsChannel reports. The fund purchased 27,066 shares of the aerospace company’s stock, valued at approximately $4,209,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Diamant Asset Management Inc. boosted its stake in Leidos by 16,475.4% during the first quarter. Diamant Asset Management Inc. now owns 4,156,784 shares of the aerospace company’s stock valued at $646,463,000 after buying an additional 4,131,706 shares during the last quarter. Goldman Sachs Group Inc. increased its stake in Leidos by 1.6% in the 4th quarter. Goldman Sachs Group Inc. now owns 1,421,634 shares of the aerospace company’s stock worth $256,463,000 after acquiring an additional 22,013 shares during the last quarter. New Age Alpha Advisors LLC raised its holdings in shares of Leidos by 25,505.4% during the 4th quarter. New Age Alpha Advisors LLC now owns 42,505 shares of the aerospace company’s stock worth $7,668,000 after acquiring an additional 42,339 shares in the last quarter. Norges Bank purchased a new stake in shares of Leidos during the 4th quarter worth approximately $318,839,000. Finally, National Pension Service boosted its position in shares of Leidos by 275.0% during the 4th quarter. National Pension Service now owns 278,134 shares of the aerospace company’s stock valued at $50,175,000 after acquiring an additional 203,958 shares during the last quarter. 76.12% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

LDOS has been the subject of a number of recent research reports. Citigroup cut their target price on shares of Leidos from $178.00 to $138.00 and set a “buy” rating for the company in a report on Wednesday. Weiss Ratings downgraded shares of Leidos from a “hold (c+)” rating to a “hold (c)” rating in a research note on Monday, June 8th. Wells Fargo & Company set a $125.00 price objective on shares of Leidos in a research report on Wednesday, June 17th. BNP Paribas Exane started coverage on shares of Leidos in a research note on Wednesday, May 27th. They issued an “outperform” rating and a $165.00 price objective for the company. Finally, Jefferies Financial Group reduced their target price on shares of Leidos from $140.00 to $110.00 and set a “hold” rating on the stock in a report on Wednesday. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $172.08.

Insider Activity

In other news, insider Elizabeth A. Porter sold 2,000 shares of the firm’s stock in a transaction dated Tuesday, April 7th. The shares were sold at an average price of $158.78, for a total value of $317,560.00. Following the completion of the sale, the insider owned 49,476 shares in the company, valued at approximately $7,855,799.28. This trade represents a 3.89% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gary Stephen May sold 1,484 shares of Leidos stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $132.75, for a total transaction of $197,001.00. Following the transaction, the director directly owned 10,137 shares of the company’s stock, valued at approximately $1,345,686.75. This represents a 12.77% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.77% of the stock is currently owned by company insiders.

Leidos Stock Performance

NYSE LDOS opened at $108.58 on Friday. The company has a market cap of $13.66 billion, a P/E ratio of 9.94, a P/E/G ratio of 1.60 and a beta of 0.54. The company has a debt-to-equity ratio of 1.19, a quick ratio of 1.29 and a current ratio of 1.40. The business’s 50 day moving average price is $122.85 and its 200-day moving average price is $157.63. Leidos Holdings, Inc. has a fifty-two week low of $98.86 and a fifty-two week high of $205.77.

Leidos (NYSE:LDOS) last released its quarterly earnings results on Tuesday, May 5th. The aerospace company reported $3.13 earnings per share for the quarter, beating the consensus estimate of $2.88 by $0.25. The company had revenue of $4.40 billion for the quarter, compared to analyst estimates of $4.28 billion. Leidos had a return on equity of 31.92% and a net margin of 8.15%.Leidos’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.97 EPS. Leidos has set its FY 2026 guidance at 12.100-12.500 EPS. Sell-side analysts predict that Leidos Holdings, Inc. will post 12.26 earnings per share for the current year.

Leidos Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Stockholders of record on Monday, June 15th were issued a $0.43 dividend. This represents a $1.72 annualized dividend and a dividend yield of 1.6%. The ex-dividend date was Monday, June 15th. Leidos’s dividend payout ratio (DPR) is 15.75%.

About Leidos

Leidos is an American technology and engineering company that provides services and solutions to government and commercial customers, with a strong focus on national security, defense, intelligence, and civil government markets. The company delivers systems integration, engineering, cybersecurity, software development, data analytics, cloud migration and managed IT services, as well as mission support for complex programs. Leidos’ work spans areas such as C4ISR (command, control, communications, computers, intelligence, surveillance and reconnaissance), secure communications, sensors and systems engineering, and health IT solutions for public-sector healthcare programs.

Leidos traces its corporate roots to Science Applications International Corporation (SAIC) and emerged as an independent, publicly traded company following a corporate separation in 2013.